Hosted on MSN
The rise of 'agonorexia': People are developing brand new eating disorders on GLP-1 agonist drugs
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...
Dr. Brynna Connor told Newsweek how small diet changes later in life can help protect people's long‑term health.
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...
Time for Ozempic to walk the plank? Top dietitians in Australia this week are waving a red flag about an unforeseen impact of the GLP-1 class of weight-loss drugs, including Ozempic, Wegovy and ...
Eating disorders are conditions that occur in people who experience a difficult relationship with food. They may face extreme ...
When people stop chasing perfect eating, their choices tend to settle into patterns shaped by time, cost, and convenience. Instead of rigid rules, meals become simpler and more repetitive, often built ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results